Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOXHIPECT4: Neoadjuvant FOLFOX With/Without HIPEC in Locally Advanced Colon Cancer
NCT06783491Phase 3Recruiting
- Sponsor
- Maimónides Institute of Biomedical Research of Córdoba
- Start
- May 2026
- Primary completion
- Jun 2030
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c, fluorouracil, folinic acid, oxaliplatin in colon cancer, sponsored by Maimónides Institute of Biomedical Research of Córdoba. Started May 2026; status: recruiting.
02
Drugs
mitomycin cfluorouracilfolinic acidoxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT06783491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06783491.